Medicilon established a well-developed structural biology research platform. Medicilon is proud as the first CRO to provide gene to crystal structure service in China. We have well-established integrated service platform, which has been certified as an important platform for drug discovery by Shanghai Government.
Medicilon has more than ten years of experiences in providing gene to crystal structure service, including construction design, protein expression and purification, high-throughput screen of crystallization conditions, compound or fragments soaking and structure determination.